Literature DB >> 23150265

Epigenetics in Parkinson's and Alzheimer's diseases.

Sueli Marques1, Tiago Fleming Outeiro.   

Abstract

Neurodegenerative disorders, such as Parkinson's and Alzheimer's disease, are highly complex, due to their multifactorial origin, not only depending on genetic but also on environmental factors. Several genetic risk factors have already been associated with both the diseases, however, the precise way through which the environment contributes to neurodegeneration is still unclear.Recently, epigenetic mechanisms, such as DNA methylation, chromatin remodeling or miRNAs, which may induce alterations in genes expression, have started to be implicated in both AD and PD. Epigenetic modulation is present since pre-natal stages and throughout lifetime, and depends on lifestyle conditions and environmental exposures, and consequently could represent the missing link between risk factors and the development of sporadic disorders. This chapter will discusses the role of epigenetics in AD and PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23150265     DOI: 10.1007/978-94-007-4525-4_22

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  12 in total

Review 1.  Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics.

Authors:  Dimitrios Athanasopoulos; George Karagiannis; Magda Tsolaki
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

2.  Developmental Dieldrin Exposure Alters DNA Methylation at Genes Related to Dopaminergic Neuron Development and Parkinson's Disease in Mouse Midbrain.

Authors:  Joseph Kochmanski; Sarah E VanOeveren; Joseph R Patterson; Alison I Bernstein
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 3.  Aß Pathology and Neuron-Glia Interactions: A Synaptocentric View.

Authors:  Christiaan F M Huffels; Jinte Middeldorp; Elly M Hol
Journal:  Neurochem Res       Date:  2022-08-17       Impact factor: 4.414

4.  EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Rev Esp Escler Mult       Date:  2014-03

5.  Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.

Authors:  Zhan Gao; Hong-Juan Fu; Ju-Jun Xue; Zhi-Xuan Wu; Li-Bo Zhao
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

6.  High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein.

Authors:  Fengju Jia; Ning Song; Weiwei Wang; Xixun Du; Yajing Chi; Hong Jiang
Journal:  Front Aging Neurosci       Date:  2018-04-06       Impact factor: 5.750

Review 7.  Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology.

Authors:  Francisco Pan-Montojo; Heinz Reichmann
Journal:  Transl Neurodegener       Date:  2014-05-09       Impact factor: 8.014

Review 8.  Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses.

Authors:  Martijn C de Wilde; Bruno Vellas; Elodie Girault; Aysun Cetinyurek Yavuz; John W Sijben
Journal:  Alzheimers Dement (N Y)       Date:  2017-06-24

9.  Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1,3-Diketones.

Authors:  Carla I Nieto; María Pilar Cornago; María Pilar Cabildo; Dionisia Sanz; Rosa M Claramunt; María Carmen Torralba; María Rosario Torres; Diana Martínez Casanova; Yaiza Rebeca Sánchez-Alegre; Esther Escudero; José Luis Lavandera
Journal:  Molecules       Date:  2018-07-24       Impact factor: 4.411

Review 10.  Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach.

Authors:  Mariano Bisbal; Mónica Sanchez
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.